Stockreport

ESSA Pharma Inc. Amends Agreement with XenoTherapeutics

ESSA Pharma Inc.  (EPIX) 
Last essa pharma inc. earnings: 2/13 05:48 pm Check Earnings Report
US:NASDAQ Investor Relations: essapharma.com/investors
PDF Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.14 per CVR under revised termsFurther Adjou [Read more]